Invitae Corp (NVTA) 13.23 $NVTA
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 11:47AM CDT
RNO: 2.09 (+0.13), ECHO: 32.68 (-1.14), LJPC: 22.95 (-1.39), CEA: 40.74 (-2.76), NVGN: 6.54 (-0.01), NHLD: 3.78 (-0.18), VLTC: 11.54 (+0.50), GEVO: 2.72 (-0.10), BIOD: 1.14 (-0.13), PRTO: 12.30 (+0.01), TTS: 14.01 (-0.17), ENZN: 1.72 (+0.18), AST: 14.77 (+0.66), VGGL: 2.55 (-0.10), GLF: 13.58 (-0.05), NVTA: 13.23 (+0.41), FTK: 14.06 (-0.43), PGN: 1.69 (unch), UCTT: 6.26 (+0.60), SANM: 20.81 (-0.03)
Invitae Presents New Data Demonstrating Use of Next-Generation Sequencing for Multi-Gene Panels at the 2015 American College of Medical Genetics Annual Clinical Genetics Meeting
Business Wire - Thu Mar 26, 11:30AM CDT
Invitae Corporation (NYSE:NVTA), a genetic information company, is presenting seven posters at the 2015 American College of Medical Genetics (ACMG) Annual Clinical Genetics Meeting, including data demonstrating the use of next-generation sequencing (NGS) technology in genetic testing, a proposed variant classification system based on ACMG guidelines, and genetic testing case studies.
NVTA: 13.23 (+0.41)
Invitae to Present Seven Posters Highlighting New Data on the Use of Next-Generation Sequencing for Multi-Gene Panels at the 2015 American College of Medical Genetics Annual Clinical Genetics Meeting
Business Wire - Tue Mar 17, 8:00AM CDT
Invitae Corporation (NYSE:NVTA), a genetic information company, today announced it will be presenting seven posters at the 2015 American College of Medical Genetics (ACMG) Annual Clinical Genetics Meeting in Salt Lake City.
NVTA: 13.23 (+0.41)
Invitae reports Q4 results
Seeking Alpha - at Seeking Alpha - Tue Mar 10, 3:20PM CDT
NVTA: 13.23 (+0.41)
Invitae Announces Fourth Quarter and 2014 Year-End Financial Results and Highlights and Provides 2015 Outlook
Business Wire - Tue Mar 10, 3:00PM CDT
Invitae Corporation (NYSE:NVTA) today reported financial and operating results for the fourth quarter and year ended December 31, 2014. Highlights for the quarter and year include:
NVTA: 13.23 (+0.41)
IPO Quiet Period Expiration: Invitae Corporation
Don Dion - at Seeking Alpha - Sat Mar 07, 11:17AM CST
NVTA: 13.23 (+0.41)
U.S. IPO Weekly Recap: No IPOs In Final Week Of A Challenging February
Renaissance Capital IPO Research - at Seeking Alpha - Tue Mar 03, 11:15AM CST
There were no initial public offerings in the past week, but recent IPO performance continues to trend up. The 24 IPOs in 2015 now average +18%, including +5% after the first day, its highest point this year. A few highlights from February 2015: ...
CHEKU: 6.01 (unch), ITEK: 5.61 (+0.86), INOV: 26.67 (-0.32), CPPL: 26.52 (-0.39), NVTA: 13.23 (+0.41), AJX: 14.28 (unch)
InsiderInsights.com Daily Round Up 2/19/15: GE, GPRO, SFNC, CRR
InsiderInsights - at Seeking Alpha - Fri Feb 20, 10:50AM CST
GPRO: 44.73 (-1.35), GE: 26.80 (-0.05), BX: 41.41 (+0.42), CRR: 31.60 (-1.26), SFNC: 43.69 (+0.64), MSON: 13.28 (-0.08), CYS: 9.15 (+0.05), WETF: 21.08 (-0.48), BBY: 35.39 (-0.74), N: 91.45 (-4.66), MLNK: 3.66 (-0.05), GOOG: 565.06 (+18.06), CI: 130.66 (+0.09), LNKD: 260.95 (+4.71), CUDA: 46.12 (+0.24), HART: 3.11 (unch), MDAS: 20.53 (+0.23), NVTA: 13.23 (+0.41), GRPN: 7.11 (-0.04), APD: 150.06 (-0.54)
Invitae completes IPO
Seeking Alpha - at Seeking Alpha - Wed Feb 18, 3:36PM CST
NVTA: 13.23 (+0.41)
Invitae Announces Completion of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Business Wire - Wed Feb 18, 3:15PM CST
Invitae Corporation (NYSE:NVTA), a genetic information company, announced today the closing of its initial public offering of 7,302,500 shares of common stock at an initial public offering price of $16.00 per share, which included 952,500 shares sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock. Total gross proceeds from the offering were approximately $116.8 million, before deducting underwriting discounts and commissions and other offering expenses. All of the shares in the offering were offered by Invitae. Invitae's common stock is listed on the New York Stock Exchange under the symbol "NVTA."
JPM: 62.60 (-0.20), NVTA: 13.23 (+0.41)
IPO Stock Watch: Health Care IPO Market Losing Grip
at Investor's Business Daily - Tue Feb 17, 1:21PM CST
The health care IPO market, after a blazing 2014, is showing signs of illness. Three small IPOs planned for this week, all hailing from the health care sector, are trying once again after previously postponing their offerings. They plan to raise a...
KITE: 60.58 (-0.35), ONCE: 61.39 (-0.66), INOV: 26.67 (-0.32), NVTA: 13.23 (+0.41), BLPH: 9.53 (-0.39)
U.S. IPO Weekly Recap: Big Data Produces Small Returns In A Selective IPO Market
Renaissance Capital IPO Research - Seeking Alpha - Sat Feb 14, 11:07PM CST
Five companies had below-average returns and brought the number of 2015 IPOs up to 22, a 39% decline from this time last year... • 5 of 12 IPOs got done ; 2nd week in a row where less than half of possible deals priced •Even as the IPO...
IDGX: (), AGMX: (), SLWD: (), ITEK: 5.61 (+0.86), REDX: (), AVNU: 11.94 (+0.29), INOV: 26.67 (-0.32), CBYL: 7.45 (-0.11), NVTA: 13.23 (+0.41), AJX: 14.28 (unch), BLPH: 9.53 (-0.39)
IPO Stock Watch: Inovalon Gets Big Data IPO Applause
at Investor's Business Daily - Thu Feb 12, 1:44PM CST
Inovalon (INOV) received a solid IPO reception Thursday in a deal that raised $600 million for the data analytics company. Inovalon provides a cloud-based health care data analytics service used by hospitals, physicians, clinical facilities and...
IMS: 29.00 (+1.02), INOV: 26.67 (-0.32), SPLK: 67.88 (+0.07), NVTA: 13.23 (+0.41), DATA: 102.40 (+0.20)
Invitae (NVTA) Stock Higher Today on NY Stock Exchange Debut
at The Street - Thu Feb 12, 1:02PM CST
Shares of Invitae Corp. (NVTA) are up after the company debuted today on the NY Stock Exchange at an initial offering price of $16.
NVTA: 13.23 (+0.41)
Invitae prices IPO above range
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 6:11AM CST
NVTA: 13.23 (+0.41)
IPO Preview: Invitae
IPOdesktop - at Seeking Alpha - Thu Feb 12, 12:00AM CST
Based in San Francisco, CA, Invitae (Pending: NVTA ) scheduled a $75 million IPO on NYSE with a market capitalization of $417 million at a price range midpoint of $14 for Thursday, Feb. 12, 2015. Priced at $16, no change in conclusion. The full...
NVTA: 13.23 (+0.41)
Invitae Announces Pricing of Initial Public Offering of Common Stock
Business Wire - Wed Feb 11, 7:05PM CST
Invitae Corporation (NYSE: NVTA), a genetic information company, announced today the pricing of its initial public offering of 6,350,000 shares of its common stock at an initial offering price of $16.00 per share, for total gross proceeds of $101.6 million before deducting underwriting discounts and commissions and other offering expenses. The shares of Invitae's common stock are expected to begin trading on the New York Stock Exchange under the symbol "NVTA" on February 12, 2015. All of the shares in the offering are being offered by Invitae. The offering is expected to close on or about February 18, 2015, subject to customary closing conditions. In addition, Invitae has granted the underwriters a 30-day option to purchase up to an additional 952,500 shares of common stock at such offering price, less customary underwriting discounts and commissions.
JPM: 62.60 (-0.20), NVTA: 13.23 (+0.41)
Invitae Genomic Testing Heading Into IPO
Don Dion - at Seeking Alpha - Wed Feb 11, 3:01PM CST
NVTA: 13.23 (+0.41)
Week Ahead: 12 IPOs Feature Healthcare, Holdovers And A $500 Million Health Tech IPO
Renaissance Capital IPO Research - Seeking Alpha - Mon Feb 09, 9:36AM CST
Twelve deals are on the calendar to raise $1.2 billion, which would make it the year's biggest week for IPOs by proceeds and count. However, those numbers could fall decline if the week ahead is similar to last week, which saw seven of eight...
IDGX: (), AGMX: (), SLWD: (), CHEK: 4.24 (+0.03), ITEK: 5.61 (+0.86), REDX: (), AVNU: 11.94 (+0.29), INOV: 26.67 (-0.32), CBYL: 7.45 (-0.11), NVTA: 13.23 (+0.41), BLPH: 9.53 (-0.39)
Invitae on deck for IPO
Seeking Alpha - at Seeking Alpha - Fri Feb 06, 12:40PM CST
NVTA: 13.23 (+0.41)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 11:47AM CDT
RNO: 2.09 (+0.13), ECHO: 32.68 (-1.14), LJPC: 22.95 (-1.39), CEA: 40.74 (-2.76), NVGN: 6.54 (-0.01), NHLD: 3.78 (-0.18), VLTC: 11.54 (+0.50), GEVO: 2.72 (-0.10), BIOD: 1.14 (-0.13), PRTO: 12.30 (+0.01), TTS: 14.01 (-0.17), ENZN: 1.72 (+0.18), AST: 14.77 (+0.66), VGGL: 2.55 (-0.10), GLF: 13.58 (-0.05), NVTA: 13.23 (+0.41), FTK: 14.06 (-0.43), PGN: 1.69 (unch), UCTT: 6.26 (+0.60), SANM: 20.81 (-0.03)
Invitae Presents New Data Demonstrating Use of Next-Generation Sequencing for Multi-Gene Panels at the 2015 American College of Medical Genetics Annual Clinical Genetics Meeting
Business Wire - Thu Mar 26, 11:30AM CDT
Invitae Corporation (NYSE:NVTA), a genetic information company, is presenting seven posters at the 2015 American College of Medical Genetics (ACMG) Annual Clinical Genetics Meeting, including data demonstrating the use of next-generation sequencing (NGS) technology in genetic testing, a proposed variant classification system based on ACMG guidelines, and genetic testing case studies.
NVTA: 13.23 (+0.41)
Invitae to Present Seven Posters Highlighting New Data on the Use of Next-Generation Sequencing for Multi-Gene Panels at the 2015 American College of Medical Genetics Annual Clinical Genetics Meeting
Business Wire - Tue Mar 17, 8:00AM CDT
Invitae Corporation (NYSE:NVTA), a genetic information company, today announced it will be presenting seven posters at the 2015 American College of Medical Genetics (ACMG) Annual Clinical Genetics Meeting in Salt Lake City.
NVTA: 13.23 (+0.41)
Invitae reports Q4 results
Seeking Alpha - at Seeking Alpha - Tue Mar 10, 3:20PM CDT
NVTA: 13.23 (+0.41)
Invitae Announces Fourth Quarter and 2014 Year-End Financial Results and Highlights and Provides 2015 Outlook
Business Wire - Tue Mar 10, 3:00PM CDT
Invitae Corporation (NYSE:NVTA) today reported financial and operating results for the fourth quarter and year ended December 31, 2014. Highlights for the quarter and year include:
NVTA: 13.23 (+0.41)
IPO Quiet Period Expiration: Invitae Corporation
Don Dion - at Seeking Alpha - Sat Mar 07, 11:17AM CST
NVTA: 13.23 (+0.41)
U.S. IPO Weekly Recap: No IPOs In Final Week Of A Challenging February
Renaissance Capital IPO Research - at Seeking Alpha - Tue Mar 03, 11:15AM CST
There were no initial public offerings in the past week, but recent IPO performance continues to trend up. The 24 IPOs in 2015 now average +18%, including +5% after the first day, its highest point this year. A few highlights from February 2015: ...
CHEKU: 6.01 (unch), ITEK: 5.61 (+0.86), INOV: 26.67 (-0.32), CPPL: 26.52 (-0.39), NVTA: 13.23 (+0.41), AJX: 14.28 (unch)
InsiderInsights.com Daily Round Up 2/19/15: GE, GPRO, SFNC, CRR
InsiderInsights - at Seeking Alpha - Fri Feb 20, 10:50AM CST
GPRO: 44.73 (-1.35), GE: 26.80 (-0.05), BX: 41.41 (+0.42), CRR: 31.60 (-1.26), SFNC: 43.69 (+0.64), MSON: 13.28 (-0.08), CYS: 9.15 (+0.05), WETF: 21.08 (-0.48), BBY: 35.39 (-0.74), N: 91.45 (-4.66), MLNK: 3.66 (-0.05), GOOG: 565.06 (+18.06), CI: 130.66 (+0.09), LNKD: 260.95 (+4.71), CUDA: 46.12 (+0.24), HART: 3.11 (unch), MDAS: 20.53 (+0.23), NVTA: 13.23 (+0.41), GRPN: 7.11 (-0.04), APD: 150.06 (-0.54)
Invitae completes IPO
Seeking Alpha - at Seeking Alpha - Wed Feb 18, 3:36PM CST
NVTA: 13.23 (+0.41)
Invitae Announces Completion of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Business Wire - Wed Feb 18, 3:15PM CST
Invitae Corporation (NYSE:NVTA), a genetic information company, announced today the closing of its initial public offering of 7,302,500 shares of common stock at an initial public offering price of $16.00 per share, which included 952,500 shares sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock. Total gross proceeds from the offering were approximately $116.8 million, before deducting underwriting discounts and commissions and other offering expenses. All of the shares in the offering were offered by Invitae. Invitae's common stock is listed on the New York Stock Exchange under the symbol "NVTA."
JPM: 62.60 (-0.20), NVTA: 13.23 (+0.41)
IPO Stock Watch: Health Care IPO Market Losing Grip
at Investor's Business Daily - Tue Feb 17, 1:21PM CST
The health care IPO market, after a blazing 2014, is showing signs of illness. Three small IPOs planned for this week, all hailing from the health care sector, are trying once again after previously postponing their offerings. They plan to raise a...
KITE: 60.58 (-0.35), ONCE: 61.39 (-0.66), INOV: 26.67 (-0.32), NVTA: 13.23 (+0.41), BLPH: 9.53 (-0.39)
U.S. IPO Weekly Recap: Big Data Produces Small Returns In A Selective IPO Market
Renaissance Capital IPO Research - Seeking Alpha - Sat Feb 14, 11:07PM CST
Five companies had below-average returns and brought the number of 2015 IPOs up to 22, a 39% decline from this time last year... • 5 of 12 IPOs got done ; 2nd week in a row where less than half of possible deals priced •Even as the IPO...
IDGX: (), AGMX: (), SLWD: (), ITEK: 5.61 (+0.86), REDX: (), AVNU: 11.94 (+0.29), INOV: 26.67 (-0.32), CBYL: 7.45 (-0.11), NVTA: 13.23 (+0.41), AJX: 14.28 (unch), BLPH: 9.53 (-0.39)
IPO Stock Watch: Inovalon Gets Big Data IPO Applause
at Investor's Business Daily - Thu Feb 12, 1:44PM CST
Inovalon (INOV) received a solid IPO reception Thursday in a deal that raised $600 million for the data analytics company. Inovalon provides a cloud-based health care data analytics service used by hospitals, physicians, clinical facilities and...
IMS: 29.00 (+1.02), INOV: 26.67 (-0.32), SPLK: 67.88 (+0.07), NVTA: 13.23 (+0.41), DATA: 102.40 (+0.20)
Invitae (NVTA) Stock Higher Today on NY Stock Exchange Debut
at The Street - Thu Feb 12, 1:02PM CST
Shares of Invitae Corp. (NVTA) are up after the company debuted today on the NY Stock Exchange at an initial offering price of $16.
NVTA: 13.23 (+0.41)
Invitae prices IPO above range
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 6:11AM CST
NVTA: 13.23 (+0.41)
IPO Preview: Invitae
IPOdesktop - at Seeking Alpha - Thu Feb 12, 12:00AM CST
Based in San Francisco, CA, Invitae (Pending: NVTA ) scheduled a $75 million IPO on NYSE with a market capitalization of $417 million at a price range midpoint of $14 for Thursday, Feb. 12, 2015. Priced at $16, no change in conclusion. The full...
NVTA: 13.23 (+0.41)
Invitae Announces Pricing of Initial Public Offering of Common Stock
Business Wire - Wed Feb 11, 7:05PM CST
Invitae Corporation (NYSE: NVTA), a genetic information company, announced today the pricing of its initial public offering of 6,350,000 shares of its common stock at an initial offering price of $16.00 per share, for total gross proceeds of $101.6 million before deducting underwriting discounts and commissions and other offering expenses. The shares of Invitae's common stock are expected to begin trading on the New York Stock Exchange under the symbol "NVTA" on February 12, 2015. All of the shares in the offering are being offered by Invitae. The offering is expected to close on or about February 18, 2015, subject to customary closing conditions. In addition, Invitae has granted the underwriters a 30-day option to purchase up to an additional 952,500 shares of common stock at such offering price, less customary underwriting discounts and commissions.
JPM: 62.60 (-0.20), NVTA: 13.23 (+0.41)
Invitae Genomic Testing Heading Into IPO
Don Dion - at Seeking Alpha - Wed Feb 11, 3:01PM CST
NVTA: 13.23 (+0.41)
Week Ahead: 12 IPOs Feature Healthcare, Holdovers And A $500 Million Health Tech IPO
Renaissance Capital IPO Research - Seeking Alpha - Mon Feb 09, 9:36AM CST
Twelve deals are on the calendar to raise $1.2 billion, which would make it the year's biggest week for IPOs by proceeds and count. However, those numbers could fall decline if the week ahead is similar to last week, which saw seven of eight...
IDGX: (), AGMX: (), SLWD: (), CHEK: 4.24 (+0.03), ITEK: 5.61 (+0.86), REDX: (), AVNU: 11.94 (+0.29), INOV: 26.67 (-0.32), CBYL: 7.45 (-0.11), NVTA: 13.23 (+0.41), BLPH: 9.53 (-0.39)
Invitae on deck for IPO
Seeking Alpha - at Seeking Alpha - Fri Feb 06, 12:40PM CST
NVTA: 13.23 (+0.41)
